CBD Oil Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : September 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC095363

CBD Oil Market By Type (Marijuana-Derived CBD Oil Products and Hemp-Derived CBD Oil Products) and Application (Anxiety, Fibromyalgia (FM), Diabetes and Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The CBD Oil Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. CBD oil is considered as a pivotal blend of substance parts that control infections and help in treatment of the patients determined to have neurological issue and different sicknesses. CBD oil is gotten from a natural substance shaped from the plant's emissions. Delta-9 tetrahydrocannabinol, or THC synthetic constituent of oil, is picking up energy in mainstream researchers and media for the utilization of europrotection, stress alleviation, safe reaction, and directing the body's general condition of equalization.

Drivers and Restraints

CBD oil helps patients experiencing distinctive endless ailments just as builds the capacity of a body to deliver normal cannabinoids so as to improve the invulnerable framework. High predominance and occurrence paces of unending illnesses, for example, disease and diabetes, expanded spotlight on diminishing pressure and wretchedness among the youthful age, and rising worries over the spread of neurological issue have prompted an expansion in use of CBD oil for treatment techniques. These variables, all things considered, are anticipated to drive the worldwide CBD oil market sooner rather than later.

Regional Insights

The market in North America is essentially determined by the quickly expanding geriatric populace and their admission to clinics because of ceaseless sickness, high appropriation of treatment methodology, and the rising frequency of neurological torment among the populace in the U.S.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • ENDOCA
  • Isodiol
  • Medical Marijuana
  • Aurora Cannabis
  • CBD American Shaman
  • Elixinol
  • Folium Biosciences
  • IRIE CBD
  • NuLeaf Naturals

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         CBD Oil Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o    Marijuana-Derived CBD Oil Products

o    Hemp-Derived CBD Oil Products

·         CBD Oil Market, By Applications, Estimates and Forecast, 2017-2027 ($Million)

o    Anxiety

o    Fibromyalgia (FM)

o    Diabetes

o    Others

·         CBD Oil Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    ENDOCA

o    Isodiol

o    Medical Marijuana

o    Aurora Cannabis

o    CBD American Shaman

o    Elixinol

o    Folium Biosciences

o    IRIE CBD

o    NuLeaf Naturals

·         CBD Oil Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America CBD Oil Market, By Country

o    U.S. CBD Oil Market

o    Canada CBD Oil Market

o    Mexico CBD Oil Market

o    Europe

§  Europe CBD Oil Market, By Country

o    Germany CBD Oil Market

o    UK CBD Oil Market

o    France CBD Oil Market

o    Russia CBD Oil Market

o    Italy CBD Oil Market

o    Rest of Europe CBD Oil Market

o    Asia-Pacific

§  Asia-Pacific CBD Oil Market, By Country

o    China CBD Oil Market

o    Japan CBD Oil Market

o    South Korea CBD Oil Market

o    India CBD Oil Market

o    Southeast Asia CBD Oil Market

o    Rest of Asia-Pacific CBD Oil Market

o    South America

§  South America CBD Oil Market

o    Brazil CBD Oil Market

o    Argentina CBD Oil Market

o    Columbia CBD Oil Market

o    Rest of South America CBD Oil Market

o    Middle East and Africa

§  Middle East and Africa CBD Oil Market

o    Saudi Arabia CBD Oil Market

o    UAE CBD Oil Market

o    Egypt CBD Oil Market

o    Nigeria CBD Oil Market

o    South Africa CBD Oil Market

o    Rest of MEA CBD Oil Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       CBD Oil Market, By Type

5.1.     Introduction

5.2.     Global CBD Oil Revenue and Market Share by Type (2017-2027)

5.2.1.  Global CBD Oil Revenue and Revenue Share by Type (2017-2027)

5.3.     Marijuana-Derived CBD Oil Products

5.3.1.  Global Marijuana-Derived CBD Oil Products Revenue and Growth Rate (2017-2027)

5.4.     Hemp-Derived CBD Oil Products

5.4.1.  Global Hemp-Derived CBD Oil Products Revenue and Growth Rate (2017-2027)

6.       CBD Oil Market, By Application

6.1.     Introduction

6.2.     Global CBD Oil Revenue and Market Share by Application (2017-2027)

6.2.1.  Global CBD Oil Revenue and Revenue Share by Application (2017-2027)

6.3.     Anxiety

6.3.1.  Global Anxiety Revenue and Growth Rate (2017-2027)

6.4.     Fibromyalgia (FM)

6.4.1.  Global Fibromyalgia (FM) Revenue and Growth Rate (2017-2027)

6.5.     Diabetes

6.5.1.  Global Diabetes  Revenue and Growth Rate (2017-2027)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       CBD Oil Market, By Region

7.1.     Introduction

7.2.     Global CBD Oil Revenue and Market Share by Regions

7.2.1.  Global CBD Oil Revenue by Regions (2017-2027)

7.3.     North America CBD Oil by Countries

7.3.1.  North America CBD Oil Revenue and Growth Rate (2017-2027)

7.3.2.  North America CBD Oil Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe CBD Oil by Countries

7.4.1.  Europe CBD Oil Revenue and Growth Rate (2017-2027)

7.4.2.  Europe CBD Oil Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific CBD Oil by Countries

7.5.1.  Asia-Pacific CBD Oil Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific CBD Oil Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America CBD Oil by Countries

7.6.1.  South America CBD Oil Revenue and Growth Rate (2017-2027)

7.6.2.  South America CBD Oil Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa CBD Oil by Countries

7.7.1.  Middle East and Africa CBD Oil Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa CBD Oil Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     ENDOCA

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Isodiol

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Medical Marijuana

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Aurora Cannabis

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     CBD American Shaman

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Elixinol

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Folium Biosciences

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     IRIE CBD

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     NuLeaf Naturals

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

9.       CBD Oil Market Forecast (2017-2027)

9.1.     Global CBD Oil Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     CBD Oil Market Forecast by Regions (2017-2027)

9.2.1.  North America CBD Oil Market Forecast (2017-2027)

9.2.1.1.  United States CBD Oil Market Forecast (2017-2027)

9.2.1.2.  Canada CBD Oil Market Forecast (2017-2027)

9.2.1.3.  Mexico CBD Oil Market Forecast (2017-2027)

9.2.2.  Europe CBD Oil Market Forecast (2017-2027)

9.2.2.1.  Germany CBD Oil Market Forecast (2017-2027)

9.2.2.2.  France CBD Oil Market Forecast (2017-2027)

9.2.2.3.  UK CBD Oil Market Forecast (2017-2027)

9.2.2.4.  Russia CBD Oil Market Forecast (2017-2027)

9.2.2.5.  Italy CBD Oil Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe CBD Oil Market Forecast (2017-2027)

9.2.3.  Asia-Pacific CBD Oil Market Forecast (2017-2027)

9.2.3.1.  China CBD Oil Market Forecast (2017-2027)

9.2.3.2.  Japan CBD Oil Market Forecast (2017-2027)

9.2.3.3.  Korea CBD Oil Market Forecast (2017-2027)

9.2.3.4.  India CBD Oil Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia CBD Oil Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific CBD Oil Market Forecast (2017-2027)

9.2.4.  South America CBD Oil Market Forecast (2017-2027)

9.2.4.1.  Brazil CBD Oil Market Forecast (2017-2027)

9.2.4.2.  Argentina CBD Oil Market Forecast (2017-2027)

9.2.4.3.  Columbia CBD Oil Market Forecast (2017-2027)

9.2.4.4.  Rest of South America CBD Oil Market Forecast (2017-2027)

9.2.5.  Middle East and Africa CBD Oil Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia CBD Oil Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates CBD Oil Market Forecast (2017-2027)

9.2.5.3.  Egypt CBD Oil Market Forecast (2017-2027)

9.2.5.4.  Nigeria CBD Oil Market Forecast (2017-2027)

9.2.5.5.  South Africa CBD Oil Market Forecast (2017-2027)

9.2.5.6.  Turkey CBD Oil Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa CBD Oil Market Forecast (2017-2027)

9.3.     CBD Oil Market Forecast by Type (2017-2027)

9.3.1.  CBD Oil Forecast by Type (2017-2027)

9.3.2.  CBD Oil Market Share Forecast by Type (2017-2027)

9.4.     CBD Oil Market Forecast by Application (2017-2027)

9.4.1.  CBD Oil Forecast by Application (2017-2027)

9.4.2.  CBD Oil Market Share Forecast by Application (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure France CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure China CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure India CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa CBD Oil Revenue (Million USD) and Growth Rate (2017-2025)
Table Global CBD Oil Revenue and Revenue Share by Type (2017-2018)
Figure Global Marijuana-Derived CBD Oil Products Revenue and Growth Rate (2017-2018)
Figure Global Hemp-Derived CBD Oil Products Revenue and Growth Rate (2017-2018)
Table Global CBD Oil Revenue and Revenue Share by Application (2017-2018)
Figure Global Anxiety Revenue and Growth Rate (2017-2018)
Figure Global Fibromyalgia (FM) Revenue and Growth Rate (2017-2018)
Figure Global Diabetes Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global CBD Oil Revenue by Regions (2017-2018)
Figure North America CBD Oil Growth Rate (2017-2018)
Figure North America CBD Oil Revenue and Growth Rate (2017-2018)
Figure North America CBD Oil by Countries (2017-2018)
Figure North America CBD Oil Revenue (Million USD) by Countries (2017-2018)
Figure United States CBD Oil Growth Rate (2017-2018)
Figure United States CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada CBD Oil Growth Rate (2017-2018)
Figure Canada CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico CBD Oil Growth Rate (2017-2018)
Figure Mexico CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe CBD Oil Growth Rate (2017-2018)
Figure Europe CBD Oil Revenue and Growth Rate (2017-2018)
Figure Europe CBD Oil by Countries (2017-2018)
Figure Europe CBD Oil Revenue (Million USD) by Countries (2017-2018)
Figure Germany CBD Oil Growth Rate (2017-2018)
Figure Germany CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France CBD Oil Growth Rate (2017-2018)
Figure France CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK CBD Oil Growth Rate (2017-2018)
Figure UK CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia CBD Oil Growth Rate (2017-2018)
Figure Russia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy CBD Oil Growth Rate (2017-2018)
Figure Italy CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe CBD Oil Growth Rate (2017-2018)
Figure Rest of Europe CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific CBD Oil Growth Rate (2017-2018)
Figure Asia-Pacific CBD Oil Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific CBD Oil by Countries (2017-2018)
Figure Asia-Pacific CBD Oil Revenue (Million USD) by Countries (2017-2018)
Figure China CBD Oil Growth Rate (2017-2018)
Figure China CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan CBD Oil Growth Rate (2017-2018)
Figure Japan CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea CBD Oil Growth Rate (2017-2018)
Figure Korea CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India CBD Oil Growth Rate (2017-2018)
Figure India CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia CBD Oil Growth Rate (2017-2018)
Figure Southeast Asia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific CBD Oil Growth Rate (2017-2018)
Figure Rest of Asia-Pacific CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America CBD Oil Growth Rate (2017-2018)
Figure South America CBD Oil Revenue and Growth Rate (2017-2018)
Figure South America CBD Oil by Countries (2017-2018)
Figure South America CBD Oil Revenue (Million USD) by Countries (2017-2018)
Figure Brazil CBD Oil Growth Rate (2017-2018)
Figure Brazil CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina CBD Oil Growth Rate (2017-2018)
Figure Argentina CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia CBD Oil Growth Rate (2017-2018)
Figure Columbia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America CBD Oil Growth Rate (2017-2018)
Figure Rest of South America CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa CBD Oil Growth Rate (2017-2018)
Figure Middle East and Africa CBD Oil Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa CBD Oil by Countries (2017-2018)
Figure Middle East and Africa CBD Oil Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia CBD Oil Growth Rate (2017-2018)
Figure Saudi Arabia CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates CBD Oil Growth Rate (2017-2018)
Figure United Arab Emirates CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt CBD Oil Growth Rate (2017-2018)
Figure Egypt CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria CBD Oil Growth Rate (2017-2018)
Figure Nigeria CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa CBD Oil Growth Rate (2017-2018)
Figure South Africa CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey CBD Oil Growth Rate (2017-2018)
Figure Turkey CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa CBD Oil Growth Rate (2017-2018)
Figure Rest of Middle East and Africa CBD Oil Revenue (Millions USD) and Growth Rate (2017-2018)
Table ENDOCA CBD Oil Financial Overview
Table Isodiol CBD Oil Financial Overview
Table Medical Marijuana CBD Oil Financial Overview
Table Aurora Cannabis CBD Oil Financial Overview
Table CBD American Shaman CBD Oil Financial Overview
Table Elixinol CBD Oil Financial Overview
Table Folium Biosciences CBD Oil Financial Overview
Table IRIE CBD CBD Oil Financial Overview
Table NuLeaf Naturals CBD Oil Financial Overview
Figure Global CBD Oil Revenue (Millions USD) and Growth Rate (2018-2025)
Table CBD Oil Market Forecast by Regions (2018-2025)
Figure North America CBD Oil Market Forecast (2018-2025)
Figure United States CBD Oil Market Forecast (2018-2025)
Figure Canada CBD Oil Market Forecast (2018-2025)
Figure Mexico CBD Oil Market Forecast (2018-2025)
Figure Europe CBD Oil Market Forecast (2018-2025)
Figure Germany CBD Oil Market Forecast (2018-2025)
Figure France CBD Oil Market Forecast (2018-2025)
Figure UK CBD Oil Market Forecast (2018-2025)
Figure Russia CBD Oil Market Forecast (2018-2025)
Figure Italy CBD Oil Market Forecast (2018-2025)
Figure Rest of Europe CBD Oil Market Forecast (2018-2025)
Figure Asia-Pacific CBD Oil Market Forecast (2018-2025)
Figure China CBD Oil Market Forecast (2018-2025)
Figure Japan CBD Oil Market Forecast (2018-2025)
Figure Korea CBD Oil Market Forecast (2018-2025)
Figure India CBD Oil Market Forecast (2018-2025)
Figure Southeast Asia CBD Oil Market Forecast (2018-2025)
Figure Rest of Asia-Pacific CBD Oil Market Forecast (2018-2025)
Figure South America CBD Oil Market Forecast (2018-2025)
Figure Brazil CBD Oil Market Forecast (2018-2025)
Figure Argentina CBD Oil Market Forecast (2018-2025)
Figure Columbia CBD Oil Market Forecast (2018-2025)
Figure Rest of South America CBD Oil Market Forecast (2018-2025)
Figure Middle East and Africa CBD Oil Market Forecast (2018-2025)
Figure Saudi Arabia CBD Oil Market Forecast (2018-2025)
Figure United Arab Emirates CBD Oil Market Forecast (2018-2025)
Figure Egypt CBD Oil Market Forecast (2018-2025)
Figure Nigeria CBD Oil Market Forecast (2018-2025)
Figure South Africa CBD Oil Market Forecast (2018-2025)
Figure Turkey CBD Oil Market Forecast (2018-2025)
Figure Rest of Middle East and Africa CBD Oil Market Forecast (2018-2025)
Figure Global CBD Oil Forecast by Type (2018-2025)
Figure Global CBD Oil Market Share Forecast by Type (2018-2025)
Figure Global CBD Oil Forecast by Type (2018-2025)
Figure Global CBD Oil Forecast by Application (2018-2025)
Figure Global CBD Oil Market Share Forecast by Application (2018-2025)
Figure Global CBD Oil Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*